{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:03:12Z","timestamp":1791421392670,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020483","name":"Insmed Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaci.2025.07.016","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T08:06:36Z","timestamp":1754467596000},"page":"1356-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigating the impact of dipeptidyl peptidase-1 inhibition in humans using multi-omics"],"prefix":"10.1016","volume":"156","author":[{"given":"Merete B.","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Hui","family":"Giam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollian","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Abo-Leyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly R.","family":"Keir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Alferes de Lima Headley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dowey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Turton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.M.","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pembridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Stobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Hui","family":"Peh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Band","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McLaren-Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Singanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A. Roger","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Gierlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Condliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-7868","authenticated-orcid":false,"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.07.016_bib1","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/antibiotics4010062","article-title":"NETs and CF lung disease: current status and future prospects","volume":"4","author":"Gray","year":"2015","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jaci.2025.07.016_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaci.2017.04.022","article-title":"Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease","volume":"141","author":"Dicker","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.07.016_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.1301920","article-title":"Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor","volume":"192","author":"Berg","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.07.016_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0241-2021","article-title":"Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy","volume":"31","author":"Keir","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2025.07.016_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00303-2019","article-title":"A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.07.016_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01702-2020","article-title":"Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study","volume":"56","author":"Gramegna","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.07.016_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239151","article-title":"Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease","volume":"14","author":"Chalmers","year":"2023","journal-title":"Front Immuno"},{"key":"10.1016\/j.jaci.2025.07.016_bib10","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI76009","article-title":"Papillon-Lef\u00e8vre syndrome patient reveals species-dependent requirements for neutrophil defenses","volume":"124","author":"S\u00f8rensen","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.07.016_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.5A1015-489R","article-title":"Characterization of neutrophil function in Papillon-Lef\u00e8vre syndrome","volume":"100","author":"Roberts","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.07.016_bib12","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.4049\/jimmunol.173.12.7277","article-title":"Papillon-Lef\u00e8vre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C\/dipeptidyl peptidase I deficiency in humans","volume":"173","author":"Pham","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.07.016_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-023-02444-z","article-title":"Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial","volume":"24","author":"Cipolla","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2025.07.016_bib14","unstructured":"Chalmers J, Burgel P, Daley C, De Soyza A, Haworth C, Mauger D, et al. A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of brensocatib administered once daily for 52 weeks in patients with non-cystic fibrosis bronchiectasis\u2014the ASPEN Study. Presented at: 7th World Bronchiectasis Conference; July 4-6, 2024; Dundee, Scotland."},{"key":"10.1016\/j.jaci.2025.07.016_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00633-2022","article-title":"A phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf","volume":"9","author":"Chalmers","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaci.2025.07.016_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00151-2024","article-title":"Brensocatib in non\u2013cystic fibrosis bronchiectasis: ASPEN protocol\/baseline characteristics","volume":"10","author":"Chalmers","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaci.2025.07.016_bib17","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","article-title":"Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo","volume":"96","author":"Pham","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.07.016_bib18","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/all.14746","article-title":"Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19","volume":"76","author":"Gu\u00e9ant","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.07.016_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S2213-2600(22)00261-2","article-title":"Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"10","author":"Keir","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00787-2023","article-title":"Extensive acute and sustained changes to neutrophil proteomes post-SARS-CoV-2 infection","volume":"63","author":"Long","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.07.016_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw0336","article-title":"Neutrophil extracellular traps drive inflammatory pathogenesis in malaria","volume":"4","author":"Knackstedt","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2025.07.016_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00917-2023","article-title":"SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID19 pandemic: a double-blind, randomised, placebo-controlled trial","volume":"10","author":"Long","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaci.2025.07.016_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40168-021-01072-3","article-title":"Ultra-accurate microbial amplicon sequencing with synthetic long reads","volume":"9","author":"Callahan","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.jaci.2025.07.016_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","volume":"104","author":"Palmer","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2025.07.016_bib25","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1200470109","article-title":"NSP4, an elastase-related protease in human neutrophils with arginine specificity","volume":"109","author":"Perera","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.07.016_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2025.07.016_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200812-1928OC","article-title":"C5a mediates peripheral blood neutrophil dysfunction in critically ill patients","volume":"180","author":"Conway Morris","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s40262-022-01147-w","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of the dipeptidyl peptidase 1 inhibitor brensocatib for non-cystic fibrosis bronchiectasis","volume":"61","author":"Chalmers","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 67","key":"10.1016\/j.jaci.2025.07.016_bib30","article-title":"Pharmacokinetics and safety of brensocatib in patients with cystic fibrosis","volume":"62","author":"Konstan","year":"2023","journal-title":"Eur Respir J"},{"issue":"6 Pt 2","key":"10.1016\/j.jaci.2025.07.016_bib31","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1164\/ajrccm\/150.6_Pt_2.S147","article-title":"Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis","volume":"150","author":"Jenne","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1189\/jlb.0808495","article-title":"Neutrophil-derived azurocidin alarms the immune system","volume":"85","author":"Soehnlein","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2025.07.016_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00062752-200301000-00005","article-title":"Neutrophil transendothelial migration and alteration in vascular permeability: focus on neutrophil-derived azurocidin","volume":"10","author":"Edens","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2025.07.016_bib34","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm1001-1123","article-title":"Heparin-binding protein (HBP\/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability","volume":"7","author":"Gautam","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.07.016_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/cc12834","article-title":"Increased plasma levels of heparin-binding protein in patients with acute respiratory distress syndrome","volume":"17","author":"Lin","year":"2013","journal-title":"Crit Care"},{"issue":"suppl 2","key":"10.1016\/j.jaci.2025.07.016_bib36","article-title":"M18 heparin-binding protein as a biomarker inflammation, symptoms and severity in bronchiectasis","volume":"74","author":"Abo-Leyah","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.07.016_bib37","author":"Shoemark"},{"key":"10.1016\/j.jaci.2025.07.016_bib38","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s11033-010-0409-3","article-title":"HNP-3 enhanced the antimicrobial activity of CIP by promoting ATP efflux from P. aeruginosa cells","volume":"38","author":"Wang","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jaci.2025.07.016_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MOH.0000000000000005","article-title":"Defensins in innate immunity","volume":"21","author":"Zhao","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2025.07.016_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1753425913514784","article-title":"Microbicidal effects of \u03b1- and \u03b8-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa","volume":"21","author":"Tai","year":"2015","journal-title":"Innate Immun"},{"key":"10.1016\/j.jaci.2025.07.016_bib41","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202408-1545OC","article-title":"Broad immunomodulatory effects of the dipeptidyl-peptidase-1 inhibitor brensocatib in bronchiectasis: data from the phase 2, double-blind, placebo-controlled WILLOW trial","author":"Johnson","year":"2025","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925008048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925008048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:28:53Z","timestamp":1778880533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925008048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0091674925008048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.07.016","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the impact of dipeptidyl peptidase-1 inhibition in humans using multi-omics","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}